  See all
 |
Articles: Clinical Pharmacology |
Prior Articles
Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy
European Journal of Obstetrics & Gynecology and Reproductive Biology, 08/25/09
Aromatase inhibitors in breast cancer
Maturitas, 08/24/09 Antidepressant Medication Use During Breastfeeding
Clinical Obstetrics and Gynecology, 08/24/09 Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist
Human Reproduction, 08/24/09 A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol
Human Reproduction, 08/24/09 Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women
Maturitas, 08/24/09 Transdermal Estradiol for Postpartum Depression: A Promising Treatment Option
Clinical Obstetrics and Gynecology, 08/24/09 A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer
Cancer Chemotherapy and Pharmacology, 08/24/09 Endometriosis-associated nerve fibers and pain
Acta Obstetricia et Gynecologica Scandinavica, 08/21/09 Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
International Journal of Women's Health, 08/21/09
Free full text
Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in HER2-Negative or Unknown Metastatic Breast Cancer
Journal of Clinical Oncology, 08/21/09 Leptin – A tocolytic agent for the future
Medical Hypotheses, 08/20/09 Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes
Cancer Chemotherapy and Pharmacology, 08/20/09 Once-monthly oral ibandronate in postmenopausal osteoporosis: Translation and updated review
Clinical Therapeutics, 08/19/09 Celecoxib in the treatment of primary dysmenorrhea: Results from two randomized, double-blind, active- and placebo-controlled, crossover studies
Clinical Therapeutics, 08/19/09 Treating postmenopausal osteoporosis in women at increased risk of fracture – critical appraisal of bazedoxifene: a review
International Journal of Women's Health, 08/18/09
Free full text
Efficacy of taxane and platinum-based chemotherapy
guided by extreme drug resistance assay in patients with
epithelial ovarian cancer
Journal of Gynecologic Oncology, 08/18/09
Free full text
Managing urogenital atrophy
Maturitas, 08/17/09 Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment
Clinical Endocrinology, 08/17/09 Tamoxifen: the drug that came in from the cold
British Journal of Cancer, 08/14/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Obstetrics and Gynecology, American Journal of Obstetrics and Gynecology
more...
|
250 Available Pages
|
|
